Long-term successfull treatment of patient with history of Systemic Lupus Erythematosus complicated with Acute Myocarditis and Dilated Cardiomyopathy – case report
DOI:
https://doi.org/10.12775/JEHS.2024.69.55406Keywords
systemic lupus erythematosus, lupus myocarditis, cardiorenal syndrome, lupus nephritisAbstract
Introduction and aim. Systemic lupus erythematosus (SLE) is a chronic, autoimmune disorder that may affect every organ. The use of immunosuppression has changed a natural course of the disease. Thereupon mortality in SLE is not only associated with implications of disease activity and its impact on cardiovascular system but also with treatment-related complications like cytopenia or increased risk of infection, which can lead to a life-threatening sepsis.
Description of the case. We present a case of a 60-year-old Caucasian female patient with a long-time history of active SLE, who has first developed nephrotic syndrome and then acute lupus myocarditis (LM) complicated by dilated cardiomyopathy.
Conclusion: The appearance of LM and its complications seem to be a landmark event in the further course of disease.
References
Zhang L, Zhu YL, Li MT, et al. Lupus Myocarditis: A Case-Control Study from China. Chin Med J (Engl). 2015;128(19):2588-2594.
Appenzeller S, Pineau CA, Clarke AE. Acute lupus myocarditis: Clinical features and outcome. Lupus. 2011;20(9):981-988. doi:10.1177/0961203310395800
Bultink IEM, de Vries F, van Vollenhoven RF, Lalmohamed A. Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls. Rheumatology (Oxford). 2021;60(1):207-216.
Ocampo-Piraquive V, Nieto-Aristizábal I, Cañas CA, Tobón GJ. Mortality in systemic lupus erythematosus: causes, predictors and interventions. Expert Rev Clin Immunol. 2018;14(12):1043-1053.
Reppe Moe S, Haukeland H, Molberg Ø, Lerang K. Long-Term Outcome in Systemic Lupus Erythematosus; Knowledge from Population-Based Cohorts. J Clin Med. 2021;10(19):4306. Published 2021 Sep 22.
Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol. 2001;13(5):345-351.
Yap DY, Tang CS, Ma MK, Lam MF, Chan TM. Survival analysis and causes of mortality in patients with lupus nephritis. Nephrol Dial Transplant. 2012;27(8):3248-3254.
Smolen JS, Landewé RBM, Bergstra SA, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update [published correction appears in Ann Rheum Dis. 2023 Mar;82(3):e76. doi: 10.1136/ard-2022-223356corr1]. Ann Rheum Dis. 2023;82(1):3-18. doi:10.1136/ard-2022-223356 ‘
Fanouriakis A, Kostopoulou M, Andersen J, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83(1):15-29. Published 2024 Jan 2. doi:10.1136/ard-2023-224762
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Mateusz Ziomek, Aleksandra Bożym, Paulina Lis, Wojciech Kaźmierski, Jakub Jurek; Anna Ziobro; Alicja Kamińska, Jakub Kozłowski, Bartłomiej Żaczek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 134
Number of citations: 0
